- Home
- TNGX vs FBRT Comparison
TNGX vs FBRT Comparison
Compare TNGX & FBRT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TNGX
- FBRT
- Stock Information
- Founded
- TNGX 2014
- FBRT 2012
- Country
- TNGX United States
- FBRT United States
- Employees
- TNGX N/A
- FBRT N/A
- Industry
- TNGX Biotechnology: Pharmaceutical Preparations
- FBRT Real Estate Investment Trusts
- Sector
- TNGX Health Care
- FBRT Real Estate
- Exchange
- TNGX Nasdaq
- FBRT Nasdaq
- Market Cap
- TNGX 723.0M
- FBRT 859.1M
- IPO Year
- TNGX N/A
- FBRT 1985
- Fundamental
- Price
- TNGX $6.53
- FBRT $10.47
- Analyst Decision
- TNGX Strong Buy
- FBRT Strong Buy
- Analyst Count
- TNGX 5
- FBRT 5
- Target Price
- TNGX $10.50
- FBRT $15.10
- AVG Volume (30 Days)
- TNGX 1.9M
- FBRT 613.8K
- Earning Date
- TNGX 08-05-2025
- FBRT 07-30-2025
- Dividend Yield
- TNGX N/A
- FBRT 13.73%
- EPS Growth
- TNGX N/A
- FBRT 18.52
- EPS
- TNGX N/A
- FBRT 0.98
- Revenue
- TNGX $40,990,000.00
- FBRT $207,768,000.00
- Revenue This Year
- TNGX N/A
- FBRT $28.21
- Revenue Next Year
- TNGX N/A
- FBRT $2.40
- P/E Ratio
- TNGX N/A
- FBRT $10.56
- Revenue Growth
- TNGX 10.09
- FBRT 16.05
- 52 Week Low
- TNGX $1.03
- FBRT $9.79
- 52 Week High
- TNGX $12.02
- FBRT $13.74
- Technical
- Relative Strength Index (RSI)
- TNGX 60.33
- FBRT 46.04
- Support Level
- TNGX $6.36
- FBRT $9.79
- Resistance Level
- TNGX $7.11
- FBRT $10.68
- Average True Range (ATR)
- TNGX 0.52
- FBRT 0.26
- MACD
- TNGX -0.13
- FBRT -0.03
- Stochastic Oscillator
- TNGX 53.15
- FBRT 56.20
About TNGX Tango Therapeutics Inc.
Tango Therapeutics Inc is a biotechnology company. It is dedicated to discovering novel drug targets and delivering the next generation of precision medicine for the treatment of cancer. It is engaged in the business of discovering and developing precision oncology therapies. It is currently developing two MTA-cooperative PRMT5 inhibitors; TNG462 for non-CNS cancers, including pancreatic and lung cancer, and TNG456, a next-generation, brain-penetrant PRMT5 inhibitor, for CNS cancers, including GBM. Its pipeline products are PRMT5 and CoREST.
About FBRT Franklin BSP Realty Trust Inc.
Franklin BSP Realty Trust Inc is a private real estate investment trust that originates, acquires, and manages a diversified portfolio of commercial real estate debt, and first mortgage loans. secured by properties located in the United States. Its segments include the real estate debt business; the real estate securities business; the real estate owned business; and the commercial real estate conduit business.